Search research articles
Contact Us
Filters
Showing results (171-180 of 194) with videos related to
Page
of 20
Sort By:
Blood
|
May 1, 1992
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
E Fischer, K J Van Zee, M A Marano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1989
Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans
Y Fong, M Rosenbaum, K J Tracey, et al.
The Journal of Infectious Diseases
|
July 1, 1997
Pretreatment with a 55-kDa tumor necrosis factor receptor-immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboons
T van der Poll, P M Jansen, K J Van Zee, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
December 1, 1988
Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils
J D Meyer, R W Yurt, R Duhaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1995
Endogenous IL-10 protects mice from death during septic peritonitis
T van der Poll, A Marchant, W A Buurman, et al.
The Journal of Surgical Research
|
April 1, 1989
Hepatocellular membrane function during chronic burn injury
J P Minei, Y Fong, M A Marano, et al.
The Journal of Clinical Investigation
|
June 1, 1990
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans
Y M Fong, M A Marano, L L Moldawer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1995
Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man
T van der Poll, K J Van Zee, E Endert, et al.
Journal of the American College of Surgeons
|
February 1, 1994
Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients
M A Rogy, S M Coyle, H S Oldenburg, et al.
The Journal of Experimental Medicine
|
November 1, 1989
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia
Y Fong, K J Tracey, L L Moldawer, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 194) with videos related to
Sort By:
Page
of 20
Blood
|
May 1, 1992
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
E Fischer, K J Van Zee, M A Marano, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1989
Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans
Y Fong, M Rosenbaum, K J Tracey, et al.
The Journal of Infectious Diseases
|
July 1, 1997
Pretreatment with a 55-kDa tumor necrosis factor receptor-immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboons
T van der Poll, P M Jansen, K J Van Zee, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
December 1, 1988
Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils
J D Meyer, R W Yurt, R Duhaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1995
Endogenous IL-10 protects mice from death during septic peritonitis
T van der Poll, A Marchant, W A Buurman, et al.
The Journal of Surgical Research
|
April 1, 1989
Hepatocellular membrane function during chronic burn injury
J P Minei, Y Fong, M A Marano, et al.
The Journal of Clinical Investigation
|
June 1, 1990
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans
Y M Fong, M A Marano, L L Moldawer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1995
Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man
T van der Poll, K J Van Zee, E Endert, et al.
Journal of the American College of Surgeons
|
February 1, 1994
Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients
M A Rogy, S M Coyle, H S Oldenburg, et al.
The Journal of Experimental Medicine
|
November 1, 1989
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia
Y Fong, K J Tracey, L L Moldawer, et al.
Page
of 20